Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Platelet lysate is more effective than activated autologous platelet-rich plasma or saline in improving hair growth after hair restoration surgery.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

A patient with complete hair loss regrew all her hair using tofacitinib.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Dupilumab for skin problems might reactivate hair loss in some patients.